Alcyone Lifesciences Announces Broad Strategic Collaboration with Roche in the Field of Intrathecal Therapies

Thursday, December 20, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

--Collaboration leverages strengths to advance the progress of intrathecal therapies to treat severe neurological conditions --

LOWELL, Mass., Dec. 20, 2018 /PRNewswire/ -- Alcyone Lifesciences, Inc., a leader in breakthrough technologies to treat

complex neurological and oncological conditions through the company's proprietary advanced precision delivery platform, announced that it has entered into a broad strategic collaboration with Roche (F. Hoffmann-La Roche Ltd), to further advance Alcyone's market-leading position in cutting-edge precision drug delivery while providing Roche a unique opportunity to optimize intrathecal therapies and develop novel antisense oligonucleotide treatment options for patients with neurological disorders.

"We are delighted to announce this strategic collaboration with the Roche neuroscience group, which represents significant potential for patients with neurological conditions," stated PJ Anand, Alcyone's chief executive officer. "We believe our intelligent intrathecal delivery platform will help to bring transformative disease-modifying therapies to help patients with severe central nervous system (CNS) conditions. This collaboration is another clear validation that Alcyone addresses a significant unmet need within biopharma's therapy development pipelines."

About Alcyone Lifesciences, Inc.Alcyone Lifesciences, based in Lowell, Massachusetts, is a privately-held biotechnology company passionately committed to applying engineering and science in the field of neurosciences and oncology to enable transformative therapies.  For more information, please visit www.alcyonels.com

ContactAlcyone Lifesciences, Inc.PJ AnandChief Executive Officer978-709-1946info@alcyonels.com

 

Cision View original content:http://www.prnewswire.com/news-releases/alcyone-lifesciences-announces-broad-strategic-collaboration-with-roche-in-the-field-of-intrathecal-therapies-300769130.html

SOURCE Alcyone Lifesciences, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store